imedecin UK tRSSNews
View Article
CSL agrees $3bn cash deal for Talecris
Wednesday, August 13, 2008 - 08:17 PM - 3 months, 1 week ago - Newspaper & TV news - FT.com - Drugs and Healthcare
CSL has agreed to buy Talecris Biotherapeutics of the US for US$3.1bn in cash, as the Australian pharmaceutical group seeks to consolidate its presence in the global plasma products market.
